Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
AVROBIO, Inc. (AVRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2023 8-K Quarterly results
Docs: "AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update"
03/23/2023 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update"
11/08/2022 8-K Quarterly results
Docs: "Provides Business Update"
08/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/17/2022 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update"
11/04/2021 8-K Quarterly results
Docs: "AVROBIO Reports Third Quarter 2021 Financial Results and Provides Business Update"
08/05/2021 8-K Quarterly results
03/18/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/06/2020 8-K Quarterly results
03/16/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 7, 2019 AVROBIO, INC. Delaware 001-38537 81-0710585 One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 914-8420 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule ...",
"AVROBIO, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update"
08/08/2019 8-K Quarterly results
05/13/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 13, 2019 AVROBIO, INC. Delaware 001-38537 81-0710585 One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 914-8420 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-...",
"AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update"
03/25/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 25, 2019 AVROBIO, INC. Delaware 001-38537 81-0710585 One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 914-8420 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13...",
"AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update"
11/13/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 13, 2018 AVROBIO, INC. Delaware 001-38537 81-0710585 One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 914-8420 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule...",
"AVROBIO, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update"
08/09/2018 8-K Quarterly results
Docs: "FORM 8-K",
"AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy